Literature DB >> 3917468

Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). I. Isolation and characterization.

K Chiba, T Nishimura, Y Hashimoto.   

Abstract

A lymphokine inhibitory for cellular DNA synthesis (termed STIF) was isolated from the culture supernatants of concanavalin A (Con A)-stimulated SD rat spleen cells. STIF inhibited the DNA synthesis of mouse bone marrow cells as well as mouse leukemia cells. STIF has an apparent m.w. of 45,000 to 50,000 and is separable from IL 2, m.w. 20,000 to 25,000, by Sephacryl S-200 gel filtration, but not from immune interferon (IFN) having the same m.w. as STIF. Con A-Sepharose chromatography of the fraction containing STIF and IFN could separate these lymphokines into Con A-unbound and Con A-bound fractions, respectively. Further fractionation of the STIF fraction by DEAE-Sephadex A-50 or Mono Q-FPLC anion exchange chromatography indicated that the STIF fraction contained two components of STIF activity, both showing the same pI value (5.1 to 5.6) on flat-bed isoelectric focusing. STIF was characterized as a sugar-free lymphokine of trypsin-sensitive protein nature.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917468

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Roles of IL-2 and antigen in the later stages of the primary antibody response.

Authors:  J Sawada; T Terao; M A Leon
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

Review 2.  Suppressin: an endogenous negative regulator of immune cell activation.

Authors:  E M Ban; R D LeBoeuf
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

3.  Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2.

Authors:  T Nishimura; Y Togashi; M Goto; H Yagi; Y Uchiyama; Y Hashimoto
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells.

Authors:  D Santoli; D J Tweardy; D Ferrero; B L Kreider; G Rovera
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

5.  Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.

Authors:  Y Nakamura; Y Tokuda; M Iwasawa; H Tsukamoto; M Kidokoro; N Kobayashi; S Kato; T Mitomi; S Habu; T Nishimura
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.